Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017

Bill: 115-hr-2410
Sponsor: Rep. Davis, Danny K. [D-IL-7]
Introduced: 2017-05-11 in the House
Policy area: Health
Subjects: Blood and blood diseases
Health care coverage and access
Health information and medical records
Health programs administration and funding
Health promotion and preventive care
Medical research
Medical tests and diagnostic methods
Minority health
Research administration and funding

Summary:
action_date: 2017-05-11
text: 

Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017

 
This bill amends the Public Health Service Act to authorize the Department of Health and Human Services to make grants to states to: (1) collect data on the prevalence and distribution of sickle cell disease, (2) conduct sickle cell disease public health initiatives to improve access to care and health outcomes, and (3) identify and evaluate strategies for prevention and treatment of sickle cell disease complications.
 The demonstration program to improve the prevention and treatment of sickle cell disease is revised, reauthorized through FY2022, and moved from the American Jobs Creation Act of 2004 to the Public Health Service Act.
action_date: 2017-10-19
text: 
(This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.)
 

Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017

 
(Sec. 2) This bill amends the Public Health Service Act to authorize the Department of Health and Human Services to make grants to states to: (1) collect data on the prevalence and distribution of sickle cell disease, (2) conduct sickle cell disease public health initiatives to improve access to care and health outcomes, and (3) identify and evaluate strategies for prevention and treatment of sickle cell disease complications.
(Sec. 4) The demonstration program to improve the prevention and treatment of sickle cell disease is revised, reauthorized through FY2022, and moved from the American Jobs Creation Act of 2004 to the Public Health Service Act.
action_date: 2018-02-26
text: 
(This measure has not been amended since it was introduced. The expanded summary of the House reported version is repeated here.)
 

Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017

 
(Sec. 2) This bill amends the Public Health Service Act to authorize the Department of Health and Human Services to make grants to states to: (1) collect data on the prevalence and distribution of sickle cell disease, (2) conduct sickle cell disease public health initiatives to improve access to care and health outcomes, and (3) identify and evaluate strategies for prevention and treatment of sickle cell disease complications.
(Sec. 4) The demonstration program to improve the prevention and treatment of sickle cell disease is revised, reauthorized through FY2022, and moved from the American Jobs Creation Act of 2004 to the Public Health Service Act.

Legislative actions:
action_date: 2018-02-27
text: Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
action_date: 2018-02-26
text: Motion to reconsider laid on the table Agreed to without objection.
action_date: 2018-02-26
text: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H1240-1241)
action_date: 2018-02-26
text: Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H1240-1241)
action_date: 2018-02-26
text: DEBATE - The House proceeded with forty minutes of debate on H.R. 2410.
action_date: 2018-02-26
text: Considered under suspension of the rules. (consideration: CR H1240-1243)
action_date: 2018-02-26
text: Mr. Burgess moved to suspend the rules and pass the bill.
action_date: 2017-10-19
text: Placed on the Union Calendar, Calendar No. 258.
action_date: 2017-10-19
text: Reported by the Committee on Energy and Commerce. H. Rept. 115-354.
action_date: 2017-10-19
text: Reported by the Committee on Energy and Commerce. H. Rept. 115-354.
action_date: 2017-06-07
text: Ordered to be Reported by Voice Vote.
action_date: 2017-06-07
text: Committee Consideration and Mark-up Session Held.
action_date: 2017-05-18
text: Forwarded by Subcommittee to Full Committee by Voice Vote .
action_date: 2017-05-18
text: Subcommittee Consideration and Mark-up Session Held.
action_date: 2017-05-12
text: Referred to the Subcommittee on Health.
action_date: 2017-05-11
text: Referred to the House Committee on Energy and Commerce.
action_date: 2017-05-11
text: Introduced in House
action_date: 2017-05-11
text: Introduced in House